Morgan Stanley raises Vir Biotechnology target price to $24
Show original
Gelonghui, February 25th｜Morgan Stanley has raised the target price of Vir Biotechnology from $20 to $24, maintaining an "Overweight" rating. (Gelonghui)
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
PoolX: Earn new token airdrops
Lock your assets and earn 10%+ APR
Lock now!
You may also like
US Stocks Movement | Oracle Rose as Much as 3% in Pre-market Trading
格隆汇•2026/02/25 11:43
Circle Announces Q4 2025 and Full Year Results: Annual Revenue Reaches $2.7 Billion, Up 64%
BlockBeats•2026/02/25 11:42
Starknet launches "plug-and-play" open-source integration solution Starkzap
Odaily星球日报•2026/02/25 11:40
Trending news
MoreCrypto prices
More
Bitcoin
BTC
$65,336.46
+3.44%
Ethereum
ETH
$1,920.08
+5.42%
Tether USDt
USDT
$1.0000
+0.02%
XRP
XRP
$1.38
+3.59%
BNB
BNB
$603.99
+2.84%
USDC
USDC
$0.9999
-0.01%
Solana
SOL
$82.86
+8.06%
TRON
TRX
$0.2861
+2.10%
Dogecoin
DOGE
$0.09403
+3.29%
Bitcoin Cash
BCH
$488.04
+2.04%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now